Esther H Zhou

ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 6

Top Venues

Pharmaceutical medicine

Pharmacoepidemiology and drug safety

JMIR public health and surveillance

Clinical toxicology (Philadelphia, Pa.)

US Food and Drug Administration

Case Western Reserve University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

US Food and Drug Administration Aug 7o 2008

United States

Senior Epidemiologist :: Center for Drug Evaluation and Research

Education History

Case Western Reserve University Jan 17o 2002 - Apr 1o 2007

United States

PHD :: Department of Epidemiology and Biostatistics

Publications

Gita A Toyserkani, Joann H Lee, Esther H Zhou
The Risk Evaluation and Mitigation Strategy (REMS) Public Dashboard: Improving Transparency of Regulatory Activities. Pharmaceutical medicine (2023)
Gita A Toyserkani, Joann H Lee, Esther H Zhou
Correction to: The Risk Evaluation and Mitigation Strategy (REMS) Public Dashboard: Improving Transparency of Regulatory Activities. Pharmaceutical medicine (2023)
Sara Karami, Cooma Asonye, Ellen Pinnow, Valerie Pratt, Lynda McCulley, Nana Dwumfour, Esther H Zhou
Trends in pediatric nonprescription analgesic/antipyretic exposures during the COVID-19 pandemic. Clinical toxicology (Philadelphia, Pa.) (2023)
Esther H Zhou, Zhou Feng, Ellen Pinnow, Joann Lee, Daniel Bak, Travis Ready, Gerald J Dal Pan
Trend changes of national zolpidem users and exposure cases after FDA drug safety communications. Pharmacoepidemiology and drug safety 30 (11) (2021)
Vincent Lo Re, Dena M Carbonari, Jerry Jacob, William R Short, Charles E Leonard, Jennifer G Lyons, Adee Kennedy, Jolene Damon, Nicole Haug, Esther H Zhou, David J Graham, Cheryl N McMahill-Walraven, Lauren E Parlett, Vinit Nair, Mano Selvan, Yunping Zhou, Gaia Pocobelli, Judith C Maro, Michael D Nguyen
Validity of ICD-10-CM diagnoses to identify hospitalizations for serious infections among patients treated with biologic therapies. Pharmacoepidemiology and drug safety 30 (7) (2021)
Michael S Sinha, Clark C Freifeld, John S Brownstein, Macarius M Donneyong, Paula Rausch, Brian M Lappin, Esther H Zhou, Gerald J Dal Pan, Ajinkya M Pawar, Thomas J Hwang, Jerry Avorn, Aaron S Kesselheim
Social Media Impact of the Food and Drug Administration's Drug Safety Communication Messaging About Zolpidem: Mixed-Methods Analysis. JMIR public health and surveillance 4 (1) (2018)

Esther H Zhou.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Esther H Zhou